Natural Product: NPC491621

Natural Product IDNPC491621
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
(S)-Cheilanthifoline
IUPAC Name (13~{S})-17-methoxy-5,7-dioxa-1-azapentacyclo[11.8.0.0^{3,11}.0^{4,8}.0^{14,19}]henicosa-3,8,10,14(19),15,17-hexaen-16-ol
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey FVXCQULKSPVRPK-HNNXBMFYSA-N
Standard InCHI InChI=1S/C19H19NO4/c1-22-18-7-12-4-5-20-9-14-11(2-3-17-19(14)24-10-23-17)6-15(20)13(12)8-16(18)21/h2-3,7-8,15,21H,4-6,9-10H2,1H3/t15-/m0/s1
SMILES COC1=CC2=C(C=C1O)[C@@H]1CC3=CC=C4OCOC4=C3CN1CC2

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   325.13 Volume:   324.737
?
Van der Waals volume.
Dense:   1.001 LogP:   1.717
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.774
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -2.656
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   1.0 Rigid Bonds:   25.0
TPSA:   51.16
?
Topological Polar Surface Area.
H-Bond Acceptor:   5.0
H-Bond Donor:   1.0 Rings:   5.0
Heavy Atoms:   5.0

MedChem Properties

QED Drug-Likeness Score:   0.874 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.119 Fsp3:   0.368
MCE-18:   86.538
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   1 PAINS Alert:   0
Colloidal aggregators:   0.617 Fluc inhibitor:   0.071
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.544
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.495
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.002 Promiscuous compounds:   0.078

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.791 MDCK Permeability:   -4.668
Pgp-inhibitor:   0.003 Pgp-substrate:   0.355
PAMPA:   0.022
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.349 30% Bioavailability (F30%):   0.025
50% Bioavailability (F50%):   0.985

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.976 MRP1:   0.967
Plasma Protein Binding (PPB):   94.634% Volume Distribution (VD):   -0.14
Fu: 4.998%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.964
OATP1B3 inhibitor:   0.953 BCRP inhibitor:   0.248
BSEP inhibitor:   0.991

ADMET: Metabolism

CYP1A2-inhibitor:   1.0 CYP1A2-substrate:   0.306
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.001
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   1.0
CYP2D6-inhibitor:   1.0 CYP2D6-substrate:   0.989
CYP3A4-inhibitor:   0.988 CYP3A4-substrate:   1.0
CYP2B6-substrate:   0.963 CYP2C8-inhibitor:   0.002
HLM stability:   0.827
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.122 Half-life (T1/2):  1.888

ADMET: Toxicity

hERG Blockers:  0.452 hERG Blockers (10um):  0.625
Human Hepatotoxicity (H-HT):  0.588 Drug-induced Liver Injury (DILI):  0.175
AMES Toxicity:  0.626 Rat Oral Acute Toxicity:  0.747
Maximum Recommended Daily Dose:  0.837 Skin Sensitization:  0.627
Carcinogencity:  0.855 Eye Corrosion:  0.003
Eye Irritation:  0.387 Respiratory Toxicity:  0.931
Drug-induced Neurotoxicity:  0.749 Ototoxicity:  0.335
Hematotoxicity:  0.226 Drug-induced Nephrotoxicity:  0.485
Genotoxicity:  0.894 RPMI-8226 Immunitoxicity:  0.089
A549 Cytotoxicity:  0.266 Hek293 Cytotoxicity:  0.44
BCF:   1.589
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.005
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.268
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.629
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO43125 Argemone mexicana L. Genus Papaveraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO54307 Lamprocapnos spectabilitis (L.) Fukuhara Genus Papaveraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO62818 Papaver somniferum L. Genus Papaveraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC491621 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC232514
0.8333 Intermediate Similarity NPC295691
0.8333 Intermediate Similarity NPC207757
0.8333 Intermediate Similarity NPC54379
0.7742 Intermediate Similarity NPC326205
0.746 Intermediate Similarity NPC204828
0.746 Intermediate Similarity NPC5238
0.7419 Intermediate Similarity NPC31311
0.7419 Intermediate Similarity NPC234392
0.7031 Intermediate Similarity NPC216459
0.7031 Intermediate Similarity NPC41178
0.7031 Intermediate Similarity NPC138487
0.6875 Remote Similarity NPC189266
0.6875 Remote Similarity NPC2413
0.6875 Remote Similarity NPC110416
0.6515 Remote Similarity NPC249797
0.6515 Remote Similarity NPC193949
0.6471 Remote Similarity NPC606650
0.6349 Remote Similarity NPC88249
0.625 Remote Similarity NPC210437
0.625 Remote Similarity NPC16107
0.625 Remote Similarity NPC106295
0.6154 Remote Similarity NPC51957
0.6143 Remote Similarity NPC276944
0.6143 Remote Similarity NPC238530
0.6119 Remote Similarity NPC172765
0.6087 Remote Similarity NPC264850
0.5735 Remote Similarity NPC39701
0.5735 Remote Similarity NPC184026
0.5694 Remote Similarity NPC146288
0.5606 Remote Similarity NPC220858
0.5588 Remote Similarity NPC151895
0.5429 Remote Similarity NPC276588
0.5429 Remote Similarity NPC127674
0.5429 Remote Similarity NPC278799
0.5373 Remote Similarity NPC111485
0.5278 Remote Similarity NPC312025
0.5217 Remote Similarity NPC147390
0.5217 Remote Similarity NPC428
0.5195 Remote Similarity NPC207239
0.5135 Remote Similarity NPC2314

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC491621 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.625 Remote Similarity NPD4584 Phase 2

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data